The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial
Authors:
- 25 November 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (4) , 713-721
Abstract
Background: The formation of calciprotein particles (CPPs) may be an important component of the humoral defences against ectopic calcification. Although magnesium (Mg) has been shown to delay the transition of amorphous calcium-/phosphate-containing primary CPP (CPP-1) to crystalline apatite-containing secondary CPP (CPP-2) ex vivo, effects on the endogenous CPP pool are unknown. Methods: We used post hoc analyses from a randomized double-blind parallel-group controlled clinical trial of 28 days treatment with high dialysate Mg of 2.0 mEq/L versus standard dialysate Mg of 1.0 mEq/L in 57 subjects undergoing maintenance hemodialysis for end-stage kidney disease. CPP load, markers of systemic inflammation and bone turnover were measured at baseline and follow-up. Results: After 28 days of treatment with high dialysate Mg, serum total CPP (−52%), CPP-1 (−42%) and CPP-2 (−68%) were lower in the high Mg group (all P < 0.001) but were unchanged in the standard dialysate Mg group. Tumour necrosis factor-α (−20%) and interleukin-6 (−22%) were also reduced with high dialysate Mg treatment (both P < 0.01). High dialysate Mg resulted in higher levels of bone-specific alkaline phosphatase (a marker of bone formation) (+17%) but lower levels of tartrate-resistant acid phosphatase 5 b (a marker of bone resorption; −33%) (both P < 0.01). Inflammatory cytokines and bone turnover markers were unchanged in the standard dialysate Mg group over the same period. Conclusions: In this exploratory analysis, increasing dialysate Mg was associated with reduced CPP load and systemic inflammation and divergent changes in markers of bone formation and resorption.Keywords
Funding Information
- Royal Melbourne Hospital Home Lottery Project
This publication has 36 references indexed in Scilit:
- Fetuin-A-Containing Calciprotein Particles Reduce Mineral Stress in the MacrophagePLOS ONE, 2013
- Serum fetuin‐A concentration and fetuin‐A‐containing calciprotein particles in patients with chronic inflammatory disease and renal failureNephrology, 2012
- Nanoparticle-Based Test Measures Overall Propensity for Calcification in SerumJournal of the American Society of Nephrology, 2012
- Clearance of Fetuin-A–Containing Calciprotein Particles Is Mediated by Scavenger Receptor-ACirculation Research, 2012
- Fetuin-A Is a Mineral Carrier Protein: Small Angle Neutron Scattering Provides New Insight on Fetuin-A Controlled Calcification InhibitionBiophysical Journal, 2010
- Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolismOsteoporosis International, 2006
- Structural Basis of Calcification Inhibition by α2-HS Glycoprotein/Fetuin-AJournal of Biological Chemistry, 2003
- Statistics Notes: The use of transformation when comparing two meansBMJ, 1996
- Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6Journal of Bone and Mineral Research, 1995
- Stabilization of amorphous calcium phosphate by Mg and ATPCalcified Tissue International, 1977